The Agency for Healthcare Research and Quality (AHRQ), through its Evidence-based Practice Centers (EPCs), sponsors the development of evidence reports and technology assessments to assist public-and private-sector organizations in their efforts to improve the quality of health care in the United States.
Introduction
Significant variation exists in both the types and definitions of outcome measures used in patient registries, even within the same clinical area. This variation reduces the utility of registries, making it difficult to compare, link, and aggregate data across the spectrum of clinical care and reporting. To address these limitations, the Agency for Healthcare Research and Quality (AHRQ) developed the Outcome Measures Framework (OMF), a conceptual model for classifying outcomes that are relevant to patients and providers across most conditions; it is intended to serve as a content model for developing harmonized outcome measures for specific clinical areas. a AHRQ is assessing the feasibility of using the OMF to develop standardized libraries of outcome measures in five clinical areas, including (1) Atrial fibrillation, (2) Asthma, (3) Depression, (4) Lung cancer, and (5) Lumbar spondylolisthesis.
b These clinical areas represent diverse populations and care settings, different treatment modalities, and varying levels of harmonization. For each clinical area, the relevant registries and observational studies are identified, and registry sponsors, informaticists, and clinical subject matter experts are invited to participate in a registry group that focuses on harmonizing outcome measures through a series of in-person and web-based meetings. A stakeholder group, including payers, patient representatives, Federal partners and health system leaders, is also assembled to discuss challenges and provide feedback on the harmonization effort.
A key goal of this effort is to standardize the definitions of the components that make up the outcome measures, so users can understand the level of comparability between measures across different systems and studies. As a final step in the harmonization process, clinical informaticists map the narrative definitions (generated by the workgroups) to standardized terminologies to produce a library of common data definitions.
This document describes the technical approach used to prepare the Standardized Library of Atrial Fibrillation Outcome Measures workbook. For reference, the narrative definitions for the minimum set of outcome measures produced by the Atrial Fibrillation Workgroup are included in Appendix A. The harmonization methodology and rationale for the measure definitions are discussed in a related publication.
Approach to Representing an Outcome Definition
For each measure, the accompanying workbook (Appendix B) contains the narrative definition and recommended reporting period (timeframe), the initial population for measurement (e.g., all atrial fibrillation patients, atrial fibrillation patients undergoing procedures), the outcome focused population (patients who experienced the outcome of interest), and the data criteria and value sets.
Electronic Health Record (EHR) data often will not contain all the requisite components of an outcome definition that would allow for the computational confirmation of that outcome. The approach used for this project is to gather the clinician's assertion of an outcome condition and as much supporting evidence as possible, so that even where the expression logic cannot computationally confirm an outcome, some structured evidence might still be available.
Relationships between events raise a challenge because relationships are often not directly asserted in an EHR. Thus, where possible, relationships have been inferred based on time stamps and intervals. Where this is not possible (e.g., cause of death), the logic requires an asserted relationship.
For each outcome, the following have been defined:
• An object representing the outcome condition itself: In many cases, the only structured data will be an assertion of an outcome, with all the supporting evidence being present in the narrative.
• Fast Healthcare Interoperability Resources (FHIR) for evidence for the outcome: These include labs, diagnostic imaging, etc.
• FHIR for additional relevant events: These might include procedures, encounters, etc.
• Temporal aspects for all events: These allow for inferred relationships.
Approach to Identifying Overlaps
A key goal of this project is to leverage existing resources and build connections across initiatives, where possible. To support that goal, the following sources were searched for overlap:
• https://ecqi.healthit.gov/: Primarily looking for overlapping criteria • https://vsac.nlm.nih.gov/: Primarily looking for overlapping value sets • C-CDA: Primarily looking for overlapping data representations • https://www.nlm.nih.gov/cde/: Primarily looking for overlapping data element definitions Each site has a specific, unique purpose, and data representations vary, so while there are some direct comparisons with similar use cases, there are also important differences both in terms of data structures and in terms of use cases. Results of the comparisons are provided below.
• https://ecqi.healthit.gov/; https://vsac.nlm.nih.gov/: o We were unable to identify any quality measures that laid out specific criteria for any of the atrial fibrillation outcomes. Quality measures generally look to the EHR problem list for an assertion that an outcome exists and generally do not attempt to define the detailed criteria for an outcome. For example, considering transient ischemic attack (TIA), quality measures will look for the presence of TIA on the problem list and do not require detailed supporting observations. Quality measures do create value sets (e.g., for TIA), and we did identify several overlapping value sets. All such value sets are housed at VSAC. o eCQMs are based on the National Quality Forum's Quality Data Model, as expressed as HL7 QRDA templates, whereas this project is based on FHIR version 1.8.0 objects. d The HL7 Clinical Quality Improvement committee is actively harmonizing QDM and FHIR resources, and a FHIR-based quality reporting format is expected to be balloted soon. o VSAC does not currently provide intentionally defined value sets. Therefore, comparisons are done based on enumerated lists.
o There are no atrial fibrillation or cardiac-specific templates or value sets in C-CDA.
• https://www.nlm.nih.gov/cde/:
o We were unable to identify any data elements that laid out specific criteria for any of the atrial fibrillation outcomes. Common data elements (CDEs) generally look for presence/absence of a condition and may associate a condition with a code system or value set. Therefore, there was minimal overlap between any atrial fibrillation outcomes and existing CDEs.
Challenges and Lessons Learned
Three challenges were encountered in translating the narrative definitions produced by the workgroup into standardized terminologies. First, the definitions for procedure-related death and major complications include the concept of complications related to a procedure or treatment. It is possible within an EHR setting to identify that an event occurred, but it is difficult and often not feasible to determine the cause of the event unless the event is recorded specifically as a procedure complication. For other events, it is feasible to identify an event that occurs in a specified time window after a procedure or treatment, but the event is not linked specifically to the procedure as a complication. In these cases, causality is assumed based on the nature of the event and the timing.
Second, it is difficult to determine whether a complication is 'major,' as defined in the major complications outcome measure. The criteria that distinguish a major complication, as specified in the definition, are 'permanent injury or death, requires intervention for treatment, or prolongs or requires hospitalization for more than 48 hours or results in re-hospitalization within 30 days.' Within the EHR setting, 'permanent' injury is not indicated; it may be assumed for events with no end date. It is also not feasible in most cases to determine if a specific complication prolonged a hospital stay.
Lastly, some definitions did not include sufficient specificity to produce standardized definitions. For example, the major bleeding definition uses 'e.g.,' rather than listing all possible critical areas or organs. Timeframe should also be specified clearly; as an example, the major bleeding definition references a hemoglobin drop of 2 g/dL, but does not specify the timeframe in which the two measurements must occur in order for the drop to count as major bleeding.
The project team will apply these lessons learned in subsequent workgroups.
A-1 
Survival

Procedure-related death
All-cause mortality within 30 days of the procedure or during the index procedure hospitalization (if the postoperative length of stay is > than 30 days). Procedurerelated deaths include those related to a complication of the procedure or treatment for a complication of the procedure.
VARC Statement (2)
Clinical Response
AF/AFL/AT Recurrence
Recurrent AF/AFL/AT is defined as AF/AFL/AT of at least 30 seconds' duration that is documented by an ECG or device recording system and occurs following catheter ablation or drug therapy. In the setting of catheter ablation, recurrent AF/AFL/AT may occur within or following the post ablation 3-month blanking period. Recurrent AF/AFL/AT that occurs within the post ablation blanking period is not considered a failure of AF ablation. Stroke: An acute episode of focal or global neurological dysfunction caused by brain, spinal cord, or retinal vascular injury as a result of hemorrhage or infarction. Symptoms or signs must persist ≥24 hours, or if documented by CT, MRI or autopsy, the duration of symptoms/signs may be less than 24 hours. Stroke may be classified as ischemic (including hemorrhagic transformation of ischemic stroke), hemorrhagic, or undetermined. Stroke disability measurement should be performed using the modified Rankin Scale (mRS) at discharge and 6 months post-discharge. The mRS scores should be recorded. Transient Ischemic Attack: Transient episode of focal neurological dysfunction caused by brain, spinal cord, or retinal ischemia without acute infarction and with signs and symptoms lasting less than 24 hours. Systemic embolism: Acute arterial insufficiency or occlusion of the extremities or any non-CNS organ associated with clinical, imaging, surgical/autopsy evidence of arterial occlusion in the absence of other likely mechanism (e.g., trauma, atherosclerosis, or instrumentation).
Workgroup recommendation
Events of Interest
Stroke An acute episode of focal or global neurological dysfunction caused by brain, spinal cord, or retinal vascular injury as a result of hemorrhage or infarction. Symptoms or signs must persist ≥24 hours, or if documented by CT, MRI or autopsy, the duration of symptoms/signs may be less than 24 hours. Stroke may be classified as ischemic (including hemorrhagic transformation of ischemic stroke), hemorrhagic, or undetermined. Stroke disability measurement should be performed using the modified Rankin Scale (mRS) at discharge and 6 months post-discharge. The mRS scores should be recorded.
ACC/AHA Key Data Elements (6)
Events of Interest
TIA Transient episode of focal neurological dysfunction caused by brain, spinal cord, or retinal ischemia without acute infarction and with signs and symptoms lasting less than 24 hours.
ACC/AHA Key Data Elements (6)
Events of Interest
Systemic embolism
Acute arterial insufficiency or occlusion of the extremities or any non-CNS organ associated with clinical, imaging, surgical/autopsy evidence of arterial occlusion in the absence of other likely mechanism (e.g., trauma, atherosclerosis, or instrumentation).
Modified from the Munich Consensus Statement (7)
Events of Interest
Major bleeding at 12 month interval of interest (no peri-procedural association)
Fatal bleeding AND/OR symptomatic bleeding in a critical area or organ, such as intracranial, intraspinal, intraocular, retroperitoneal, intraarticular, pericardial, or intramuscular with compartment syndrome AND/OR bleeding causing a fall in hemoglobin level of 2 g/dL (1.24 mmol/L) or more, or leading to transfusion of two or more units of blood.
ISTH definition (8)
A-3 OMF CATEGORY OUTCOME MEASURE DEFINITION REFERENCE
Events of Interest
Periprocedural bleeding (any bleeding during 12-month interval which occurs within 30d of procedure)
Major bleeding: Fatal bleeding AND/OR symptomatic bleeding in a critical area or organ, such as intracranial, intraspinal, intraocular, retroperitoneal, intraarticular, pericardial, or intramuscular with compartment syndrome AND/OR bleeding causing a fall in hemoglobin level of 2 g/dL (1.24 mmol/L) or more, or leading to transfusion of two or more units of blood. Clinically relevant non-major bleeding: An acute or subacute clinically overt bleed that does not meet the criteria for a major bleed but prompts a clinical response such that it leads to one of the following: hospital admission for bleeding; physician-guided medical or surgical treatment for bleeding; change in antithrombotic therapy (including interruption or discontinuation). Minor bleeding: All nonmajor bleeds. Minor bleeds are further divided into clinically relevant and not. Note: Registries should clearly report how they communicate with patients (phone, inperson visit) to obtain information on bleeding events.
ISTH definition (8)
A-4 OMF CATEGORY OUTCOME MEASURE DEFINITION REFERENCE
Events of Interest
Myocardial infarction
The term acute myocardial infarction (MI) should be used when there is evidence of myocardial necrosis in a clinical setting consistent with acute myocardial ischemia. Under these conditions any one of the following criteria meets the diagnosis for MI: Third universal definition of myocardial infarction (9) 
